Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP780342.RA-2KNrhI1clioKQCUeLgWqenKjUw-KU4MLdL6DTMr_HY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP780342.RA-2KNrhI1clioKQCUeLgWqenKjUw-KU4MLdL6DTMr_HY130_assertion type Assertion NP780342.RA-2KNrhI1clioKQCUeLgWqenKjUw-KU4MLdL6DTMr_HY130_head.
- NP780342.RA-2KNrhI1clioKQCUeLgWqenKjUw-KU4MLdL6DTMr_HY130_assertion description "[Sorafenib enhances the antitumor effects of chemoradiation treatment by downregulating ERCC-1 and XRCC-1 DNA repair proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP780342.RA-2KNrhI1clioKQCUeLgWqenKjUw-KU4MLdL6DTMr_HY130_provenance.
- NP780342.RA-2KNrhI1clioKQCUeLgWqenKjUw-KU4MLdL6DTMr_HY130_assertion evidence source_evidence_literature NP780342.RA-2KNrhI1clioKQCUeLgWqenKjUw-KU4MLdL6DTMr_HY130_provenance.
- NP780342.RA-2KNrhI1clioKQCUeLgWqenKjUw-KU4MLdL6DTMr_HY130_assertion SIO_000772 21551262 NP780342.RA-2KNrhI1clioKQCUeLgWqenKjUw-KU4MLdL6DTMr_HY130_provenance.
- NP780342.RA-2KNrhI1clioKQCUeLgWqenKjUw-KU4MLdL6DTMr_HY130_assertion wasDerivedFrom befree-20150227 NP780342.RA-2KNrhI1clioKQCUeLgWqenKjUw-KU4MLdL6DTMr_HY130_provenance.
- NP780342.RA-2KNrhI1clioKQCUeLgWqenKjUw-KU4MLdL6DTMr_HY130_assertion wasGeneratedBy ECO_0000203 NP780342.RA-2KNrhI1clioKQCUeLgWqenKjUw-KU4MLdL6DTMr_HY130_provenance.